Tuberculosis. Spain is different and the oblivion of the BCG vaccine;Tuberculosis. España es diferente y el olvido del BCG

Anales de Pediatria

Volumn 64, Issue 1, 2006, Pages 1-4

  Perez Trallero E ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; EDITORIAL; HUMAN; IMMUNIZATION; PEDIATRICS; PREVALENCE; SPAIN; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 33644501499     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083825     Document Type: Editorial

References (22)

1. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005;293:2767-75.
2. United Nations Development Programme. Human Development Report (HDR), 2005. Disponible en: http://hdr.undp.org/statistics/data/
3. WHO. Global tuberculosis control - surveillance, planning, financing. WHO Report 2005. Disponible en: http://www.who. int/tb/publications/global_report/ 2005/en/
4. Grupo de Trabajo del PMIT. Incidencia de tuberculosis en España: resultados del Proyecto Multicéntrico de Investigación en Tuberculosis (PMIT). Med Clin (Barc). 2000;114:530-7.
5. García Calabuig MA. Tuberculosis en la CAPV. Boletín Epidemiológico. Salud Pública. Número 18. 1er trimestre. 2005. p. 4-5. Disponible en: http://www.euskadi.net/r33-2288/es/contenidos/ informacion/boletin_epidem/es_5482/adjuntos/18bolepidemiol_c.pdf
6. United Nations Development Programme. Leading global health crises and risks. Human Development Report (HDR), 2005. Disponible en: http://hdr.undp.org/ statistics/data/pdf/hdr05_table_9.pdf
7. Ordobás Gavín M, Fernández Rodríguez S, Cañellas Llabrés S, Rodríguez Artalejo F. Prevalencia de infección tuberculosa y su relación con la clase social en niños de la Comunidad de Madrid. An Pediatr (Barc). 2006;64:34-9.
8. Altet Gómez MN, Alcaide Megías J. Control y eliminación de la tuberculosis en España: las estrategias para el siglo XXI. An Pediatr (Barc). 2006;64:66-73.
9. Grupo de trabajo de Tuberculosis de la Sociedad Española de Infectología Pediátrica. Documento de consenso sobre el tratamiento de la exposición a tuberculosis y de la infección tuberculosa latente en niños. An Pediatr (Barc). 2006;64:59-65.
10. WHO. Estimated HIV prevalence in TB cases, 2002. Global Tuberculosis Control Surveillance, Planning, Financing. WHO REPORT 2004. Disponible en: http://www.who.int/tb/publications/global_report/2004/en/full.pdf
11. WHO. Reported estimates of BCG coverage. 2005. Disponible en: http://www.who.int/immunization_monitoring/en/global-summary/timeseries/ tscoveragebcg.htm
12. International Union Against Tuberculosis and Lung Disease. Criteria for discontinuation of vaccination programmes using Bacille Calmette Guerin (BCG) in countries with a low prevalence of tuberculosis. Tubercle and Lung Disease. 1994;75: 179-81.
13. Palme IB, Larsson LO, Zedenius I, Gillman A, Bennet R. Outbreak of tuberculosis in a Stockholm nursery affects 35 children. Eurosurveillance Weekly, 27 October 2005. Disponible en: http://www.eurosurveillance.org/ew/2005/ 051027.asp
14. Pina JM, Rodés A, Alcaide JM, Plasència A, Domínguez A. Outbreak of tuberculosis in a Catalonian nursery school affects 27 children. Eurosurveillance Weekly, 12 May 2005. Disponible en: http://www. eurosurveillance.org/ew/2005/050512.asp
15. Calendrier vaccinal 2005. Bulletin Épidémiologique Hebdomadaire N.° 29-30, 5 Juillet 2005. Disponible en: http://www. invs.sante.fr/beh/2005/29_30/beh_29_30_2005.pdf
16. Fine PE, Carneiro IAM, Milstien JB, Clements CJ. Issues relating to the use of BCG in immunization programmes. A discussion document. WHO 1999. Disponible en: http://www.who.int/vaccines-documents/DocsPDF99/www9943.pdf
17. Commission suisse pour les vaccinations, Ligue pulmonaire Suisse, Office fédéral de la santé publique. Nouvelles recommandations suisses en matière de vaccination par BCG. 2003. Disponible en: http://www.swiss-paediatrics.org/paediatrica/vol14/n2/bcgdir-fr.html
18. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis. 2004;4:761-76.
19. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet. 2005;366:1443-51.
20. Xing Z, Santosuosso M, McCormick S, Yang TC, Millar J, Hitt M, et al. Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines. Curr Gene Ther. 2005;5:485-92.
21. McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med. 2004;10:1240-4.
22. McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis (Edinb). 2005;85:47-52.